Page last updated: 2024-08-18

pyridostigmine bromide and acetylglucosamine

pyridostigmine bromide has been researched along with acetylglucosamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, YL; Li, DL; Liu, LZ; Wu, Q; Xue, RQ; Yu, XJ; Zang, WJ	1

Other Studies

1 other study(ies) available for pyridostigmine bromide and acetylglucosamine

Article	Year
Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling. Life sciences, 2019, Apr-01, Volume: 222 Topics: Acetylcholine; Acetylglucosamine; AMP-Activated Protein Kinase Kinases; Animals; Cholinergic Agents; Cholinesterase Inhibitors; Diet, High-Fat; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Protein Kinases; Pyridostigmine Bromide; Receptor, Muscarinic M3	2019

Article

Year

Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling.

Life sciences, 2019, Apr-01, Volume: 222

Topics: Acetylcholine; Acetylglucosamine; AMP-Activated Protein Kinase Kinases; Animals; Cholinergic Agents; Cholinesterase Inhibitors; Diet, High-Fat; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Protein Kinases; Pyridostigmine Bromide; Receptor, Muscarinic M3

2019